drugset / Trial / NCT02170038
Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol
Non-randomizedCrossoverOpen-labelBasic science
Summary
The clinical phase I study aims at investigating the conversion of the contraceptive compound norethisterone within the body towards the contraceptive compound ethinylestradiol. Therefore concentrations of ethinylestradiol will be measured from blood samples after administration of a single intramuscular dose of norethisterone. In a comparison arm concentrations of ethinylestradiol will be measured from blood samples after administration of a pill containing ethinylestradiol itself.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-12
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ethinyl estradiol | Small molecule | 0.03 mg | Oral |
| Subject | norethisterone enantate | Unknown | 200 mg | Intramuscular |
| Background | Levonorgestrel | Small molecule | 0.15 mg | Oral |
Indications
No indication recorded.